Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies.

Elmaaty, A ; Eldehna, W ; M, Khattab ; Kutkat, O ; Alnajjar, R ; El-Taweel, A ; Al-Rashood, S ; Abourehab, M ; Binjubair, F ; Saleh, M (2022-11-07)

Article

URI: http://repository.limu.edu.ly/handle/123456789/4549


Show full item record
Collections:
Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States